Provided by Tiger Trade Technology Pte. Ltd.

Nektar Therapeutics

68.71
-1.9450-2.75%
Volume:262.74K
Turnover:18.35M
Market Cap:2.35B
PE:-10.62
High:71.41
Open:71.41
Low:68.50
Close:70.65
52wk High:109.00
52wk Low:33.40
Shares:34.14M
Float Shares:28.53M
Volume Ratio:0.59
T/O Rate:0.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.4680
EPS(LYR):-9.7254
ROE:-35.75%
ROA:-12.54%
PB:2.60
PE(LYR):-7.06

Loading ...

May 08, 2026

Major Issues Report

Form 8-K - Current report
May 06, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Apr 23, 2026

Major Issues Report

Form 8-K - Current report
Apr 20, 2026

Major Issues Report

Form 8-K - Current report
Apr 20, 2026

Major Issues Report

Form 8-K - Current report
Apr 17, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Mar 13, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2026

Major Issues Report

Form 8-K - Current report
Feb 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 13, 2026

Major Issues Report

Form 8-K - Current report
Feb 10, 2026

Major Issues Report

Form 8-K - Current report
Feb 10, 2026

Major Issues Report

Form 8-K - Current report
Jan 27, 2026

Major Issues Report

Form 8-K - Current report
Jan 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2025

Major Issues Report

Form 8-K - Current report
Nov 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities